Forbes Advisor compares Zepbound and Wegovy, two weekly weight loss shots
An explainer on how the two weekly injections differ, starting with their separate active ingredients.
Recap by typeshit. Full story at Forbes.
Read at Forbes
More peptides
-
A look at whether the munchies feel different for people on a GLP-1 
A look at whether the munchies feel different for people on a GLP-1
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
-
Philstar Life on celebrities and the weight loss drug Ozempic Philstar Life on celebrities and the weight loss drug Ozempic
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
-
Food and agribusiness expert says fibre is gaining ground with the GLP-1 trend 
Food and agribusiness expert says fibre is gaining ground with the GLP-1 trend
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
-
Experimental injection that makes fat cells self destruct shows early promise 
Experimental injection that makes fat cells self destruct shows early promise
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
-
WSJ finds Chinese fentanyl ingredient makers now selling bootleg peptides in the US peptides typeshitSafetyWSJ finds Chinese fentanyl ingredient makers now selling bootleg peptides in the US
The Wall Street Journal reports black-market producers are pitching Americans substances for tanning, tissue repair and weight loss.
-
Novo and Lilly say GLP-1 drugs slowed aging clocks by about two to three years peptides typeshitResearchNovo and Lilly say GLP-1 drugs slowed aging clocks by about two to three years
Both drugmakers shared aging clock data at a Boston longevity conference. Novo's study drew blood from 10,052 people, and aging clock inventor Steve Horvath called the effect strong.